Search

Your search keyword '"Service de rhumatologie [CHU Cochin]"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Service de rhumatologie [CHU Cochin]" Remove constraint Author: "Service de rhumatologie [CHU Cochin]"
211 results on '"Service de rhumatologie [CHU Cochin]"'

Search Results

1. 2018 update of French recommendations on the management of postmenopausal osteoporosis

2. Assessment of typical SpA lesions on MRI of the spine: do local readers and central readers agree in the DESIR-cohort at baseline?

3. 2016 update of the EULAR recommendations for the management of early arthritis

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

5. La fatigue au cours de la spondyloarthrite axiale débutante. Résultats de la cohorte française DESIR

6. Le délai diagnostique de la spondyloarthrite axiale : une étude transversale sur 432 patients

7. Remission is related to CRP and smoking in early axial spondyloarthritis. The DESIR cohort

8. Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France

9. Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort

10. Preliminary definitions of ‘flare’ in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative

11. The Economic Burden of Severe Osteoporotic Fractures in the French Healthcare Database: The FRACTOS Study

12. EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

13. Response to: 'Correspondence on 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Fallon et al

14. 2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

15. Recommandations françaises de la prise en charge et du traitement de l’ostéoporose masculine

16. MTX optimization or adding bDMARD equally improve disease activity in rheumatoid arthritis: results from the prospective study STRATEGE

17. Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo

18. Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in lupus women: the French GR2 study

19. The initial ActConnect study was supported by unrestricted academic grants from

20. Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

21. Barriers and Expectations for Patients in Post-Osteoporotic Fracture Care in France: The EFFEL Study

22. Sociodemographic determinants in the evolution of pain in inflammatory rheumatic diseases: results from ESPOIR and DESIR cohorts

23. Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings

24. The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis - methodology and baseline characteristics of the population

25. Update of French society for rheumatology recommendations for managing rheumatoid arthritis

26. Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis

27. Is there a place for CAR‐T cells in the treatment of chronic autoimmune rheumatic diseases?

28. Refracture And Mortality Following Hospitalization For Severe Osteoporotic Fractures: The Fractos Study

29. Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional study of 150 patients

30. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

31. To apply the recent EULAR recommendations, more knowledge on adherence patterns to medication and to physical activity is needed

32. Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis

33. The adherence questionnaires in chronic inflammatory rheumatic diseases and their psychometric properties: A systematic literature review

34. Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis

35. Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa

36. Metacarpophalangeal impairment in hand osteoarthritis is not rare and is associated with mechanical factors: Results from the DIGICOD hand osteoarthritis cohort

37. Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early Rheumatoid Arthritis

38. EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future

39. Fluctuation of pain is frequent in rheumatoid arthritis and axial spondyloarthritis: A 12 weeks prospective study of 165 patients

40. Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis

41. Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks

42. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response

43. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

44. Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort

45. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease

46. Patient global assessment and radiographic progression in early arthritis: 3‐year results from the ESPOIR cohort

47. Outcomes and findings of the international rheumatoid arthritis (RA) BIODAM cohort for validation of soluble biomarkers in RA

48. What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts

49. Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

50. Dactylitis in early spondyloarthritis. data from the desir cohort

Catalog

Books, media, physical & digital resources